Doç. Dr. Osman Köstek
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Lung Neoplasms 13 publicationsSource: OpenAlex / PubMed MeSHView publications
- Colorectal Neoplasms 9 publications
- Liver Neoplasms 8 publications
- Carcinoma, Non-Small-Cell Lung 8 publications
- Carcinoma, Hepatocellular 6 publications
- Breast Neoplasms 6 publications
- Colonic Neoplasms 6 publications
- Carcinoma, Renal Cell 5 publications
- Kidney Neoplasms 5 publications
- Neoplasms 4 publications
- Hypertension 4 publications
- Coronary Artery Disease 4 publications
- Brain Neoplasms 3 publications
- Stomach Neoplasms 3 publications
- Lung Diseases, Interstitial 2 publications
- Melanoma 2 publications
- Adenocarcinoma, Mucinous 2 publications
- Rectal Neoplasms 2 publications
- Sarcoma 2 publications
- Soft Tissue Neoplasms 2 publications
- Urinary Bladder Neoplasms 2 publications
- Cardiovascular Diseases 2 publications
- Psoriasis 2 publications
- Amyloidosis 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologysaglik.gov.trFrom source
- InstitutionMarmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workLung NeoplasmsExtracted from 13 publications · Model version —From source
- Publications197 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-1901-5603ORCIDFrom source
- Last synchronised5 November 2026 10:37https://marmaraeah.saglik.gov.tr/TR-1393453/doktorlarimiz.html#osman-kosteksaglik.gov.tr
Scientific work
Publications on Lung Neoplasms
-
Which patients with colorectal cancer develop brain metastases? A multicenter analysis of clinical and molecular predictors.
Journal of Clinical Oncology, 2026
DOI 10.1200/jco.2026.44.2_suppl.218 Open-access full textSource: OpenAlex
-
Clinicopathologic and molecular characteristics of colorectal cancer patients with brain metastases: a multicenter cohort study
Scientific Reports, 2026
DOI 10.1038/s41598-026-69206-x Open-access full textSource: OpenAlex
-
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
Immunotherapy, 2026
DOI 10.1080/1750743x.2026.2662201 PMID 42011533 4 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma
Journal of International Medical Research, 2026
DOI 10.1177/03000605251386599 PMID 41521150 Open-access full textSource: OpenAlex
-
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors
JCO Global Oncology, 2026
DOI 10.1200/go-25-00234 PMID 41855443 Open-access full textSource: OpenAlex
-
Predictors of Recurrence Following Curative-Intent Local Therapy for Oligometastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study from the Turkish Oncology Group (TOG)
Eurasian Journal of Medical Investigation, 2026
DOI 10.14744/ejmi.2612571 Source: ORCID
-
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15134901 PMID 42452362 Open-access full textSource: ORCID
-
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Current Oncology, 2026
DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex
-
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15020798 PMID 41598735 Open-access full textSource: ORCID
-
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15020890 PMID 41598826 2 citations (Europe PMC) Open-access full textSource: ORCID